Sertacream 2% - cream for mycosis 30 g

Product Description

Cream for the treatment of mycoses.

Indications

Sertacream 2% is a cream for the topical treatment of skin mycoses such as dermatophytosis, Tinea pedis, Tinea capitis, Tinea cruris, Tinea corporis, Tinea barbae and Tinea manus; Candidiasis (Moniliasis) and Pityriasis versicolor (Malassezia furfur, Pityrosporum orbiculare).

Composition

Active ingredients
100 grams of cream contain 2 g of Sertaconazole Nitrate.

Excipients
Polyethylene glycols and ethylene glycol palmito stearates (Tefose 63), polyoxyethylened lauropalmitostearic glycerides (Labrafil M-2130-CS), glycerol mono-diisostearate, vaseline oil, methyl- Parahydroxybenzoate, sorbic acid, purified water.

Directions for use and Dosage

The product is intended for adult patients only.
Average recommended dose: the cream should be applied lightly and evenly once or twice a day to the affected areas, also covering approximately 1 cm of surrounding healthy skin.
The amount to be applied varies and depends on the size of the affected area.
The duration of treatment to achieve healing varies from one patient to another, depending on the etiological agent and the location of the infection.
In general, 4 weeks of treatment are recommended to ensure complete healing, although in many cases clinical-microbiological healing occurs between the second and fourth week.

Warnings

Do not use for ophthalmic treatments.
There are currently no studies on the use of the drug in pediatrics.
The use, especially if prolonged, of topical products can give rise to sensitization phenomena.
The product contains methyl p-hydroxybenzoate: slightly irritating to the skin, eyes and mucous membranes.

Contraindications

Hypersensitivity to the active substance or to any of the excipients.

Interactions

No interactions with other substances have been reported.

Side effects

No toxic or photosensitizing effects have been reported to date.
During the first few days of treatment, no case of local and transient erythematous reaction requiring treatment discontinuation has been reported.
As with all imidazoles, particularly following prolonged use, episodes of local irritation (such as burning and itching) may occur.

Overdose

The concentration of the active substance and the method of administration are such as to make intoxication impossible, however in case of accidental ingestion, appropriate symptomatic treatment will be carried out.

Pregnancy and breastfeeding

After topical application of large quantities of the drug, no traces have ever been found in plasma; despite this, its complete safety in pregnant women has not yet been demonstrated, therefore the risk/benefit ratio must be evaluated before applying the product during pregnancy and breastfeeding.

Storage

Store at a temperature not exceeding 25°C, in a dry place, in the original packaging to protect the medicine from light.

Format

30 g